The formulation base, namely, the chemical defined medium (CDM) for TNBC cells, increased the population of cancer stem cells (CD44+/CD24− phenotype) compared to DMEM, which is consistent with the literature51 (Fig. 2a). Here, CD44 is linked to cancer.